血清黑激素预测肝硬化患者的肝脏脑病变
Dinesh Jothimani1, Evangeline Simon2, Abraham Sam Rajan P M3
1Institute of Liver Disease and Transplantation, Dr Rela Institute and Medical Center, CLC Works Road, Chrompet, Chennai, 600 044, India. Dinesh.Jothimani@relainstitute.com.
概括
肝硬化患者的血清黑激素水平显著升高,肝硬化脑病 (HE),随着HE的严重程度而增加. 一个≥85 pg/mL的水平准确地预测了这些患者的HE.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 神经学 神经学
- 内分泌学 在内分泌学.
背景情况:
- 肝脑病变 (HE) 是肝硬化的一种严重并发症,影响病发率和死亡率.
- 调节睡眠的神经保护性激素 - - 黑色素 (melatonin) 在肝硬化患者中可能会受到干扰.
研究的目的:
- 评估血清黑激素在被诊断为HE的肝硬化患者中的作用.
- 为了确定黑激素水平和HE的严重程度之间的相关性.
主要方法:
- 一项前性观察性研究,涉及52名住院肝硬化患者.
- 根据HE严重程度的West Haven标准 (WHC) 分类为三组.
- 测量早晨血清黑激素水平和生物化学参数.
主要成果:
- 血清黑激素水平在肝硬化患者 (190 pg/mL) 与健康志愿者 (23.88 pg/mL) 相比显著更高.
- 黑色素水平随着HE严重程度的增加:第一组 (没有HE) 45.62 pg/mL,第二组 (轻度至中度HE) 214.01 pg/mL,第三组 (严重HE) 280.98 pg/mL (p < 0.001).
- 黑激素水平≥85 pg/mL预测HE具有86.96%的灵敏度和100%的特异性 (AUROC 0.94,p < 0.001).
结论:
- 肝硬化患者的血清黑激素水平显著升高,与疾病严重程度相关.
- 黑素可以作为肝硬化中HE的潜在诊断和预后生物标志物.
- 需要进一步的大规模研究来验证黑激素作为预后标记物的作用.
相关概念视频
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
186
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
186
02:27Predicting Molecular Geometry
45.5K
VSEPR Theory for Determination of Electron Pair Geometries
45.5K
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
260
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
260
01:21Hepatic Portal System
5.5K
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
5.5K
01:03Prediction Intervals
3.3K
The interval estimate of any variable is known as the prediction interval. It helps decide if a point estimate is dependable.
However, the point estimate is most likely not the exact value of the population parameter, but close to it. After calculating point estimates, we construct interval estimates, called confidence intervals or prediction intervals. This prediction interval comprises a range of values unlike the point estimate and is a better predictor of the observed sample value, y.
However, the point estimate is most likely not the exact value of the population parameter, but close to it. After calculating point estimates, we construct interval estimates, called confidence intervals or prediction intervals. This prediction interval comprises a range of values unlike the point estimate and is a better predictor of the observed sample value, y.
3.3K
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
219
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
219